The company is still working to get debt holder approval for the Accredited deal....
Behind the Headlines: Lloyd's results 2023 and Tokio Marine Kiln's Syal on the record
Insurance Insider editor in chief Catrin Shi helps unpack Lloyd’s preliminary 2023 results, and offers her perspective on Aviva’s acquisition of Probitas....
Insurance Insider editor in chief Catrin Shi helps unpack Lloyd’s preliminary 2023 results, and offers her perspective on Aviva’s acquisition of Probitas....
Podcast / 4 days ago
R&Q launches sales process for remainder of legacy group
The company is still working to get debt holder approval for the Accredited deal....
The company is still working to get debt holder approval for the Accredited deal....
Article / 5 days ago
Probitas-Aviva: If at first you don't succeed, try, try, try again
Aviva will need to manage the talent base deftly to get the most from the deal....
Aviva will need to manage the talent base deftly to get the most from the deal....
Article / 14 days ago
Bathia: £242mn Aviva-Probitas deal is ‘validation' of Lloyd's recovery
Lloyd's is now an attractive environment for entrepreneurs, the CEO said....
Lloyd's is now an attractive environment for entrepreneurs, the CEO said....
Article / 14 days ago
R&Q is evaluating ‘any and all' options for legacy business
The company reiterated its commitment to consummating the Accredited sale....
The company reiterated its commitment to consummating the Accredited sale....
Article / 18 days ago
Legacy firm Darag has pivoted from sale to break-up
Its PE owners have been exploring strategic options since May last year....
Its PE owners have been exploring strategic options since May last year....
Article / 26 days ago
Broker M&A in 2024: A harder sell following economic turbulence
Investors are still keen on UK broking – but they may expect more for their money....
Investors are still keen on UK broking – but they may expect more for their money....
Article / 1 month ago
AJ Gallagher paid $301.6mn for Australia's My Plan Manager
According to its 2023 10K, Gallagher spent $3.74bn on M&A activity....
According to its 2023 10K, Gallagher spent $3.74bn on M&A activity....
Article / 1 month ago
Ex-Ambridge M&A insurance team working on MGA start-up Devonshire
Sources said the initiative includes former Ambridge executive MD Jeff Doran....
Sources said the initiative includes former Ambridge executive MD Jeff Doran....
Article / 1 month ago
Jensten reconsiders strategic options as process reaches impasse
The Livingbridge-backed broker may return to market in 2025....
The Livingbridge-backed broker may return to market in 2025....
Article / 1 month ago